Literature DB >> 25359567

What role do bacteria play in persisting fistula formation in idiopathic and Crohn's anal fistula?

P J Tozer1, N Rayment, A L Hart, N Daulatzai, A U Murugananthan, K Whelan, R K S Phillips.   

Abstract

AIM: The aetiology of Crohn's disease-related anal fistula remains obscure. Microbiological, genetic and immunological factors are thought to play a role but are not well understood. The microbiota within anal fistula tracts has never been examined using molecular techniques. The present study aimed to characterize the microbiota in the tracts of patients with Crohn's and idiopathic anal fistula.
METHOD: Samples from the fistula tract and rectum of patients with Crohn's and idiopathic anal fistula were analysed using fluorescent in situ hybridization, Gram staining and scanning electron microscopy were performed to identify and quantify the bacteria present.
RESULTS: Fifty-one patients, including 20 with Crohn's anal fistula, 18 with idiopathic anal fistula and 13 with luminal Crohn's disease and no anal fistula, were recruited. Bacteria were not found in close association with the luminal surface of any of the anal fistula tracts.
CONCLUSION: Anal fistula tracts generally do not harbour high levels of mucosa-associated microbiota. Crohn's anal fistulas do not seem to harbour specific bacteria. Alternative explanations for the persistence of anal fistula are needed. Colorectal Disease
© 2014 The Association of Coloproctology of Great Britain and Ireland.

Entities:  

Keywords:  Crohn's; anal fistula; microbiology

Mesh:

Year:  2015        PMID: 25359567     DOI: 10.1111/codi.12810

Source DB:  PubMed          Journal:  Colorectal Dis        ISSN: 1462-8910            Impact factor:   3.788


  7 in total

Review 1.  Pathogenesis and persistence of cryptoglandular anal fistula: a systematic review.

Authors:  Jeremy Sugrue; Johan Nordenstam; Herand Abcarian; Amelia Bartholomew; Joel L Schwartz; Anders Mellgren; Philip J Tozer
Journal:  Tech Coloproctol       Date:  2017-06-15       Impact factor: 3.781

Review 2.  Treatments for the amelioration of persistent factors in complex anal fistula.

Authors:  Daniel P Fitzpatrick; Carmel Kealey; Damien Brady; Martin Goodman; Noel Gately
Journal:  Biotechnol Lett       Date:  2021-11-19       Impact factor: 2.461

3.  Managing perianal Crohn's fistula in the anti-TNFα era.

Authors:  P Tozer; D W Borowski; A Gupta; N Yassin; R Phillips; A Hart
Journal:  Tech Coloproctol       Date:  2015-08-12       Impact factor: 3.781

4.  Significant presence of biofilm-producing gut-derived bacteria in anal fistula of chronic duration.

Authors:  Prakhar Jaiswal; Swati Sharma; Arvind Pratap; Mumtaz Ansari; Vijay K Shukla; Somprakas Basu; Tuhina Banerjee
Journal:  Int Wound J       Date:  2021-02-05       Impact factor: 3.315

5.  Pro-inflammatory cytokines in cryptoglandular anal fistulas.

Authors:  R S van Onkelen; M P Gosselink; M van Meurs; M J Melief; W R Schouten; J D Laman
Journal:  Tech Coloproctol       Date:  2016-07-11       Impact factor: 3.781

Review 6.  Current concepts in the pathogenesis of cryptoglandular perianal fistula.

Authors:  Marcin Włodarczyk; Jakub Włodarczyk; Aleksandra Sobolewska-Włodarczyk; Radzisław Trzciński; Łukasz Dziki; Jakub Fichna
Journal:  J Int Med Res       Date:  2021-02       Impact factor: 1.671

7.  Human Amniotic Membrane for the Treatment of Cryptoglandular Anal Fistulas.

Authors:  Carlo Ratto; Ornella Parolini; Angelo Alessandro Marra; Valentina Orticelli; Angelo Parello; Paola Campennì; Veronica De Simone; Diletta Trojan; Francesco Litta
Journal:  J Clin Med       Date:  2022-03-01       Impact factor: 4.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.